Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Alveofact 50mg Injection
Manufacturer/Marketed By : BHARAT SERUMS & VACCINES LTD
$37.48 $30.36
Alveofact 50mg Injection contains an active component called Phospholipid fraction from bovine lung. It is used as medication primarily in the treatment of respiratory distress syndrome (RDS) in premature infants....
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Active Pharmaceutical Ingredient
Alveofact 50mg Injection
37.48$
30.36$
Alveofact 50mg Injection contains an active component called Phospholipid fraction from bovine lung. It is used as medication primarily in the treatment of respiratory distress syndrome (RDS) in premature infants. This condition occurs when the lungs don't produce enough surfactant, a substance essential for maintaining the lungs' elasticity and preventing alveoli collapse. In severe cases of pneumonia, especially in premature infants or newborns, where lung function is compromised, this medication might be used to support breathing. In some cases, this medication might assist with lung function when babies pass stool (meconium) while still in the womb and inhale it into their lungs before or during delivery, causing breathing problems. Individuals with known severe allergies to components of the Alveofact 50mg Injection or any of its components should not receive it. In some cases, active or severe infections may be a contraindication to this medication due to the potential risk of worsening the infection or complicating the treatment. It might not be recommended for infants above a certain gestational age or weight threshold, as their lung maturity might not benefit from this intervention. If the patient has a severe bleeding disorder or an increased risk of bleeding, administering it may pose a risk of bleeding into the lungs or exacerbate bleeding issues, so should consult a healthcare provider before taking it. Alveofact 50mg Injection is primarily used in neonatal care and is not typically administered to older adults.
Active Pharmaceutical Ingredient
Uses
• Neonatal respiratory distress syndrome (RDS)
• Meconium aspiration syndrome
• Pneumonia
• Acute respiratory distress syndrome (ARDS)
• Lung surfactant deficiency
Benefits
Alveofact 50mg Injection reduces surface tension at the air-liquid interface in the lungs' alveoli, preventing collapse during exhalation and ensuring these tiny air sacs stay open for gas exchange. Composed of lipids and proteins, it enhances lung compliance, making breathing easier. In conditions like respiratory distress syndrome (RDS) or surfactant deficiencies, surfactant replacement therapy supplements or replaces insufficient surfactant, improving lung function and preventing breathing complications.
Side Effects
Alveofact 50mg Injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Transient oxygen desaturation
• Changes in heart rate
• Breathing difficulties
Common Side Effects
• Airway blockage
• Infection
• Allergic reactions
• Pulmonary hemorrhage
How To Use
Alveofact 50mg Injection should be used only when there is enough facility for ventilation and monitoring. This medicine should be administered via the intra-tracheal route. Your baby’s physician and nurse should constantly monitor to ensure that the right amount of oxygen is given. Dosing shall be stopped by the physician in case of a slow heartbeat or reduced oxygen in circulation and resumed only after the condition is stable.
Safety Advice
• Breast Feeding: Breastfeeding individuals should consult healthcare providers before handling or administering Alveofact 50mg Injection due to potential risks associated with exposure to the medication or its residues.
• Alcohol: There's no direct contraindication regarding alcohol consumption and Alveofact 50mg Injection. Consult your healthcare provider for better advice.
• Liver: There's limited information available regarding the impact of Alveofact 50mg Injection. It is recommended to consult your healthcare provider for personalized advice.
• Lungs: Consult your health care provider before taking Alveofact 50mg Injection if you have lung diseases.
• Driving: Alveofact 50mg Injection does not typically directly affect driving ability. If you experience any side effects, consult your healthcare provider.
• Pregnancy: Alveofact 50mg Injection is not directly associated with pregnancy or breastfeeding concerns, as it is primarily used in neonates and infants. However, pregnant individuals should consult healthcare providers before handling or administering surfactant medications due to potential risks associated with exposure to the medication or its residues.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.